Dr. Linda Martin, Dr. Alan Redd, David Melvin, and John Fratti submitted an abstract for the UMDF Symposium on behalf of the FQ community. We are pleased to announce that, after being peer-reviewed by the UMDF Abstract Review Committee, their abstract was selected as a poster for the Symposium.
“The legal and Industry Guidance bars are not too high. The problem is that the FDA has failed to do its job regarding Fluoroquinolone antibiotic safety.”, Dr. Charles Bennett, PharmedOut 2015
On June 10th, 2015 representatives from the Fluoroquinolone community met with Senate Staffers at the Dirksen Senate Building in Washington, D.C. to ensure pressure is maintained on the FDA in regards to updated warnings.
“You can’t do what I do and think the drug companies don’t notice you.” With the media scrutiny and the Citizen Petitions filed over the last year you can bet that Bennett has gotten the attention of some very powerful entities; entities that are going to push back in an effort to silence or undermine our message.
Charles Bennett MD PhD Chair of the Center for Economic Excellence in Medication Safety and Efficacy, Bennett-flashUniversity of South Carolina will be speaking at the PharmedOut’s 5th Annual Conference on June 11-12, 2015 at Georgetown University about Fluoroquinolones..
Our FQ team will be working closely with Dr. Golomb as she takes research to the next level in the near future. Stay tuned here as I will be sure to inform the FQ community of any pertinent developments with her, along with developments with other researchers that we work with.
It is my regret to inform those reading, as a founding member and first director of the Quinolone Vigilance Foundation (QVF), I am forced to withdraw my support of the QVF and have no confidence in its current leadership.